Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Neuropeptides in Alzheimer's disease: a postmortem study.

Nemeroff CB, Kizer JS, Reynolds GP, Bissette G.

Regul Pept. 1989 Apr;25(1):123-30.

PMID:
2566190
2.

Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease-associated protein.

Nemeroff CB, Bissette G, Slotkin TA, Seidler FJ, Miller BE, Ghanbari H.

Ann N Y Acad Sci. 1991;640:193-6.

PMID:
1685644
3.

Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.

Bissette G, Reynolds GP, Kilts CD, Widerlöv E, Nemeroff CB.

JAMA. 1985 Dec 6;254(21):3067-9.

PMID:
3877182
4.

Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease.

Horgan J, Miguel-Hidalgo JJ, Thrasher M, Bissette G.

J Alzheimers Dis. 2007 Sep;12(2):115-27.

5.

Effects of sertraline on regional neuropeptide concentrations in olfactory bulbectomized rats.

Bissette G.

Pharmacol Biochem Behav. 2001 May-Jun;69(1-2):269-81.

PMID:
11420095
6.

Biochemical and neuropeptide alterations in Alzheimer's disease.

Bissette G, Nemeroff CB.

Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:33A-34A. No abstract available.

PMID:
1354039
8.

Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease.

De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW.

Nature. 1986 Feb 13-19;319(6054):593-5.

PMID:
3003585
9.

Peptides in the neocortex in Alzheimer's disease and ageing.

Ferrier IN, Leake A.

Psychoneuroendocrinology. 1990;15(2):89-95. Review.

PMID:
1972799
10.

Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in Alzheimer's disease and control postmortem human brain.

Behan DP, Khongsaly O, Owens MJ, Chung HD, Nemeroff CB, De Souza EB.

J Neurochem. 1997 May;68(5):2053-60.

11.

[Neuropeptides in Alzheimer's disease].

Jiménez-Corral C, Morán-Sánchez JC, Alonso-Navarro H.

Rev Neurol. 2006 Mar 16-31;42(6):354-9. Review. Spanish.

12.

Regional Neuropeptide Pathology in Alzheimer's Disease: Corticotropin-Releasing Factor and Somatostatin.

Bissette G, Cook L, Smith W, Dole KC, Crain B, Nemeroff CB.

J Alzheimers Dis. 1998 Dec;1(2):91-105.

PMID:
12214006
13.
14.

Neuropeptides in Alzheimer type dementia.

Ferrier IN, Cross AJ, Johnson JA, Roberts GW, Crow TJ, Corsellis JA, Lee YC, O'Shaughnessy D, Adrian TE, McGregor GP, et al.

J Neurol Sci. 1983 Dec;62(1-3):159-70.

PMID:
6199464
16.

Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression.

Biggins JA, Perry EK, McDermott JR, Smith AI, Perry RH, Edwardson JA.

J Neurol Sci. 1983 Jan;58(1):117-22.

PMID:
6405015
17.

Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.

Leake A, Perry EK, Perry RH, Jabeen S, Fairbairn AF, McKeith IG, Ferrier IN.

Biol Psychiatry. 1991 Feb 15;29(4):357-64.

PMID:
1674664
18.

Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease.

Behan DP, Heinrichs SC, Troncoso JC, Liu XJ, Kawas CH, Ling N, De Souza EB.

Nature. 1995 Nov 16;378(6554):284-7.

19.
20.

Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease.

Ichai C, Chevallier N, Delaere P, Dournaud P, Epelbaum J, Hauw JJ, Vincent JP, Checler F.

J Neurochem. 1994 Feb;62(2):645-55.

PMID:
7905027

Supplemental Content

Support Center